Alcresta Therapeutics

Alcresta Therapeutics is a specialty pharmaceutical company developing enzyme-based products that improve fat absorption and digestive health for people with rare and chronic conditions. Its lead product, the RELiZORB (immobilized lipase) cartridge, uses the company's patented iLipase microbead technology to mimic pancreatic lipase and hydrolyze fats in enteral (tube) feeding formulas, helping patients with exocrine pancreatic insufficiency, cystic fibrosis, short bowel syndrome, and critical-care nutrition needs absorb fatty acids they otherwise could not. Alcresta is backed by Bessemer Venture Partners. The company operates a corporate and product marketing website but publishes no public developer API, SDKs, or machine-readable API specifications at this time.

Alcresta Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotech, Pharmaceuticals, Rare Disease, and Enzyme Therapy.

Alcresta Therapeutics’ developer surface includes support, engineering blog, and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

15.0/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechPharmaceuticalsRare DiseaseEnzyme TherapyEnteral NutritionDigestive HealthMedical DeviceLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 15.0/100 · emerging

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/alcresta-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: alcresta-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/alcresta-therapeutics.png
name: Alcresta Therapeutics
description: Alcresta Therapeutics is a specialty pharmaceutical company developing enzyme-based products that improve fat
  absorption and digestive health for people with rare and chronic conditions. Its lead product, the RELiZORB (immobilized
  lipase) cartridge, uses the company's patented iLipase microbead technology to mimic pancreatic lipase and hydrolyze fats
  in enteral (tube) feeding formulas, helping patients with exocrine pancreatic insufficiency, cystic fibrosis, short bowel
  syndrome, and critical-care nutrition needs absorb fatty acids they otherwise could not. Alcresta is backed by Bessemer
  Venture Partners. The company operates a corporate and product marketing website but publishes no public developer API,
  SDKs, or machine-readable API specifications at this time.
url: https://raw.githubusercontent.com/api-evangelist/alcresta-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- bessemer-venture-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotech
- Pharmaceuticals
- Rare Disease
- Enzyme Therapy
- Enteral Nutrition
- Digestive Health
- Medical Device
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/alcresta-therapeutics-domain-security.yml
- type: Website
  url: https://www.alcresta.com/
- type: Support
  url: https://www.alcresta.com/contact/
- type: Blog
  url: https://www.alcresta.com/investors-news/
- type: TermsOfService
  url: https://www.alcresta.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.alcresta.com/privacy-policy/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence